hydroxyindoleacetic acid has been researched along with Diabetes Mellitus, Type 1 in 3 studies
(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Munawar, N | 1 |
| Bitar, MS | 1 |
| Masocha, W | 1 |
| De Block, CE | 1 |
| Colpin, G | 1 |
| Thielemans, K | 1 |
| Coopmans, W | 1 |
| Bogers, JJ | 1 |
| Pelckmans, PA | 1 |
| Van Marck, EA | 1 |
| Van Hoof, V | 1 |
| Martin, M | 1 |
| De Leeuw, IH | 1 |
| Bouillon, R | 1 |
| Van Gaal, LF | 1 |
| Nolan, B | 1 |
| Mitchell, TH | 1 |
3 other studies available for hydroxyindoleacetic acid and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Activation of 5-HT1A Receptors Normalizes the Overexpression of Presynaptic 5-HT1A Receptors and Alleviates Diabetic Neuropathic Pain.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, | 2023 |
Neuroendocrine tumor markers and enterochromaffin-like cell hyper/dysplasia in type 1 diabetes.
Topics: Autoantibodies; Biomarkers, Tumor; Chromogranin A; Chromogranins; Diabetes Mellitus, Type 1; Enteroc | 2004 |
Autonomic neuropathy with gastropathy and elevated urinary 5-hydroxy indole acetic acid in insulin-dependent diabetes mellitus.
Topics: Autonomic Nervous System Diseases; Diabetes Mellitus, Type 1; Humans; Hydroxyindoleacetic Acid; Stom | 1996 |